Lung cancer screening feasibility in Australia

The National Lung Screening Trial (NLST) reported a 20% relative reduction in lung cancer-specific mortality using low-dose computed tomography (LDCT) screening [1]. US Preventative Services Task Force modelling [2] illustrates the potentially large benefits of screening, yet nationwide population-b...

Full description

Saved in:
Bibliographic Details
Published inThe European respiratory journal Vol. 45; no. 6; pp. 1734 - 1737
Main Authors Marshall, Henry M, Bowman, Rayleen V, Ayres, John, Crossin, Jane, Lau, Melanie, Slaughter, Richard E, Redmond, Stanley, Passmore, Linda, McCaul, Elizabeth, Courtney, Deborah, Leong, Steven C, Windsor, Morgan, Zimmerman, Paul V, Yang, Ian A, Fong, Kwun M
Format Journal Article
LanguageEnglish
Published England 01.06.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The National Lung Screening Trial (NLST) reported a 20% relative reduction in lung cancer-specific mortality using low-dose computed tomography (LDCT) screening [1]. US Preventative Services Task Force modelling [2] illustrates the potentially large benefits of screening, yet nationwide population-based screening has not been adopted. Controversial issues include high false positivity, and uncertain cost-effectiveness and relative applicability to different settings and countries [3-6]. The Queensland Lung Cancer Screening Study (QLCSS) is the first study to assess NLST screening protocol feasibility in Australia.
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0903-1936
1399-3003
DOI:10.1183/09031936.00208714